Adam H. Schechter

CIK: 0001376841

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)9 (24.3%)

Position reduction

Option Exercises (M)6 (16.2%)

Derivative conversions

Awards (A)14 (37.8%)

Compensation grants

Other (G, F, J, C, D, …)8 (21.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

DVA

DAVITA INC.

Director

LABCORP HOLDINGS INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (37 total)

DVA
DAVITA INC.
Aug 15, 2026
Award(A)
Direct
278 shares-
LH
LABCORP HOLDINGS INC.
Aug 11, 2026
Sale(S)
Direct
4.7K shares at avg. $320.37$1.5M
DVA
DAVITA INC.
May 15, 2026
Award(A)
Direct
250 shares-
LH
LABCORP HOLDINGS INC.
May 11, 2026
Sale(S)
Direct
5.9K shares at avg. $254.50$1.5M
LH
LABCORP HOLDINGS INC.
Mar 26, 2026
Tax Payment(F)
Direct
26.1K shares at avg. $268.38$7.0M
LH
LABCORP HOLDINGS INC.
Mar 26, 2026
Award(A)
Direct
58.5K shares-
DVA
DAVITA INC.
Mar 15, 2026
Award(A)
Direct
332 shares-
LH
LABCORP HOLDINGS INC.
Mar 3, 2026
Sale(S)
Direct
8.7K shares at avg. $279.96$2.4M
LH
LABCORP HOLDINGS INC.
Feb 11, 2026
Exercise(M)
Direct
3.7K shares-
LH
LABCORP HOLDINGS INC.
Feb 11, 2026
Tax Payment(F)
Direct
1.5K shares at avg. $289.89$441K
LH
LABCORP HOLDINGS INC.
Feb 11, 2026
Sale(S)
Direct
5.3K shares at avg. $284.38$1.5M
LH
LABCORP HOLDINGS INC.
Feb 10, 2026
Award(A)
Restricted Stock Unit
Direct
10.4K shares-
LH
LABCORP HOLDINGS INC.
Feb 10, 2026
Award(A)
Non-qualified Stock Options
Direct
31.7K shares-
LH
LABCORP HOLDINGS INC.
Feb 9, 2026
Tax Payment(F)
Direct
1.4K shares at avg. $274.01$370K
LH
LABCORP HOLDINGS INC.
Feb 7, 2026
Exercise(M)
Direct
3.2K shares-
LH
LABCORP HOLDINGS INC.
Feb 6, 2026
Exercise(M)
Direct
4.5K shares-
LH
LABCORP HOLDINGS INC.
Feb 6, 2026
Tax Payment(F)
Direct
1.3K shares at avg. $277.20$365K
DVA
DAVITA INC.
Nov 15, 2025
Award(A)
Direct
411 shares-
LH
LABCORP HOLDINGS INC.
Nov 11, 2025
Sale(S)
Direct
5.7K shares at avg. $262.75$1.5M
DVA
DAVITA INC.
Aug 15, 2025
Award(A)
Direct
369 shares-
LH
LABCORP HOLDINGS INC.
Aug 11, 2025
Sale(S)
Direct
5.6K shares at avg. $266.78$1.5M
DVA
DAVITA INC.
May 15, 2025
Award(A)
Direct
348 shares-
LH
LABCORP HOLDINGS INC.
May 12, 2025
Sale(S)
Direct
6.1K shares at avg. $248.73$1.5M
LH
LABCORP HOLDINGS INC.
Mar 27, 2025
Tax Payment(F)
Direct
13.6K shares at avg. $231.67$3.1M
LH
LABCORP HOLDINGS INC.
Mar 27, 2025
Award(A)
Direct
30.5K shares-

		Type	Shares	Price		Ownership
Aug 15, 2026	DVA DAVITA INC.	Award(A)	278	-	$0	Direct
Aug 11, 2026	LH LABCORP HOLDINGS INC.	Sale(S)	4,669	$320.37	$1,495,808	Direct
May 15, 2026	DVA DAVITA INC.	Award(A)	250	-	$0	Direct
May 11, 2026	LH LABCORP HOLDINGS INC.	Sale(S)	5,903	$254.50	$1,502,314	Direct
Mar 26, 2026	LH LABCORP HOLDINGS INC.	Tax Payment(F)	26,106	$268.38	$7,006,328	Direct
Mar 26, 2026	LH LABCORP HOLDINGS INC.	Award(A)	58,470	-	$0	Direct
Mar 15, 2026	DVA DAVITA INC.	Award(A)	332	-	$0	Direct
Mar 3, 2026	LH LABCORP HOLDINGS INC.	Sale(S)	8,705	$279.96	$2,437,047	Direct
Feb 11, 2026	LH LABCORP HOLDINGS INC.	Exercise(M)	3,656	-	$0	Direct
Feb 11, 2026	LH LABCORP HOLDINGS INC.	Tax Payment(F)	1,521	$289.89	$440,923	Direct
Feb 11, 2026	LH LABCORP HOLDINGS INC.	Sale(S)	5,273	$284.38	$1,499,536	Direct
Feb 10, 2026	LH LABCORP HOLDINGS INC.	Award(A) Restricted Stock Unit	10,440	-	-	Direct
Feb 10, 2026	LH LABCORP HOLDINGS INC.	Award(A) Non-qualified Stock Options	31,700	-	-	Direct
Feb 9, 2026	LH LABCORP HOLDINGS INC.	Tax Payment(F)	1,352	$274.01	$370,462	Direct
Feb 7, 2026	LH LABCORP HOLDINGS INC.	Exercise(M)	3,249	-	$0	Direct
Feb 6, 2026	LH LABCORP HOLDINGS INC.	Exercise(M)	4,460	-	$0	Direct
Feb 6, 2026	LH LABCORP HOLDINGS INC.	Tax Payment(F)	1,315	$277.20	$364,518	Direct
Nov 15, 2025	DVA DAVITA INC.	Award(A)	411	-	-	Direct
Nov 11, 2025	LH LABCORP HOLDINGS INC.	Sale(S)	5,745	$262.75	$1,509,499	Direct
Aug 15, 2025	DVA DAVITA INC.	Award(A)	369	-	-	Direct
Aug 11, 2025	LH LABCORP HOLDINGS INC.	Sale(S)	5,643	$266.78	$1,505,440	Direct
May 15, 2025	DVA DAVITA INC.	Award(A)	348	-	-	Direct
May 12, 2025	LH LABCORP HOLDINGS INC.	Sale(S)	6,105	$248.73	$1,518,497	Direct
Mar 27, 2025	LH LABCORP HOLDINGS INC.	Tax Payment(F)	13,584	$231.67	$3,147,005	Direct
Mar 27, 2025	LH LABCORP HOLDINGS INC.	Award(A)	30,469	-	-	Direct

1-25 of 37 transactions

About Schechter Adam H

Schechter Adam H (SEC CIK 0001376841) files insider reports with the SEC as Director of DAVITA INC. (DVA) and President & CEO of LABCORP HOLDINGS INC. (LH).

Signal8 holds 22 ownership filings by Schechter Adam H, all Form 4s, filed between Nov 13, 2024 and Aug 18, 2026. Those filings report 37 transactions, from Nov 11, 2024 to Aug 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Schechter Adam H's filings is in BURLINGTON, NC.

Recent filings by Schechter Adam H

Aug 15, 2026: Grant or award of DVA shares (Form 4, code A).
Aug 11, 2026: Open-market sale of LH shares (Form 4, code S).
May 15, 2026: Grant or award of DVA shares (Form 4, code A).
May 11, 2026: Open-market sale of LH shares (Form 4, code S).
Mar 26, 2026: Tax withholding of LH shares (Form 4, code F).

Other insiders filing for DAVITA INC. (DVA)

BERKSHIRE HATHAWAY INC, 10% Owner
Maughan David Paul, Chief Operating Officer, DKC
Hollar Jason M., Director
DESOER BARBARA J, Director
Moore Gregory J., Director
Pullin Dennis W, Director

How to read Form 4 transaction codes